Now I have comprehensive content. Let me compile the full response.
The Well-Woman Examination
Source: Textbook of Family Medicine, 9e — "Patient-Centered Approach to the Well-Woman Examination"
Purpose
The well-woman visit is an opportunity to promote health, prevent disease, and strengthen the physician-patient relationship. While traditionally centered on an annual Pap smear, modern guidelines have broadened its scope and de-emphasized the Pap as a yearly requirement. Building a trusting relationship is essential — women are more likely to disclose sensitive problems with a physician they trust, and some may have had prior negative experiences with pelvic examinations.
Evidence-Based Screening (USPSTF Grade A & B)
| Condition | Recommendation | Grade |
|---|
| Hypertension | Screen every 2 yr if BP <120/80; yearly if 120–139/80–89 mmHg | A |
| Cervical cancer (Pap smear) | Every 3 yr ages 21–65; or every 5 yr ages 30–65 with co-HPV testing | A |
| Chlamydia | All sexually active women ≤24 yr | A |
| Lipid disorders | Women ≥45 yr at increased cardiovascular risk | A |
| Colorectal cancer | Adults 50–75 yr (FOBT, sigmoidoscopy, or colonoscopy) | A |
| Tobacco use | Screen all adults; cessation interventions | A |
| HIV | Screen ages 15–65 (any age if high risk) | A |
| Breast cancer (mammography) | Every 2 yr for women 50–74 yr | B |
| Alcohol misuse | Screen + behavioral counseling | B |
| Depression | Screen when staff-assisted support is in place | B |
| Obesity | Screen; intensive behavioral/counseling interventions | B |
| Osteoporosis | Women ≥65 yr and younger women at increased risk | B |
| Type 2 diabetes | Adults with BP >135/80 mmHg | B |
| Hepatitis C | Adults born 1945–1965 | B |
| Intimate partner violence | Screen women of childbearing age | B |
| Lipid disorders | Women 20–44 yr at increased cardiovascular risk | B |
What Is NOT Recommended (potential for harm)
- Cervical cancer screening after hysterectomy for benign disease
- Gonorrhea screening in low-risk women
- Teaching breast self-examination
- Ovarian cancer screening
Pap Smear Guidelines
Key points:
- Begin Pap screening at age 21 (regardless of sexual activity onset)
- Repeat every 3 years (ages 21–65)
- Women ≥30 years: co-testing with Pap + HPV every 5 years is acceptable
- Stop at age 65 if prior results have been normal
- Women post-hysterectomy for benign disease: no screening needed
- A Pap smear is not required before starting hormonal contraception
HPV is the most common STI, with peak prevalence in the 20–24-year-old age group (~54%). Risk factors include number of sexual partners, age at first intercourse, and low socioeconomic status. Young women frequently clear HPV without intervention; older women are less likely to acquire new infections.
Immunizations
Recommended vaccines for women (per CDC/ACIP):
| Vaccine | Target Group |
|---|
| Tdap (tetanus, diphtheria, pertussis) | All adults |
| Influenza | Annual, all adults |
| Herpes zoster | Adults ≥50 years |
| Pneumococcal | Adults ≥65 years |
| HPV | Women ≤26 years |
Women are often caregivers for children or elderly persons who are at higher risk from vaccine-preventable illness — making immunization particularly impactful.
Abnormal Uterine Bleeding
Commonly encountered at well-woman visits. Key management principles:
- Anovulatory bleeding (unpredictable, heavy or light) results from lack of progesterone → unopposed estrogen → irregular endometrial growth
- Treatment not necessary unless the woman desires pregnancy, is symptomatic, or has anemia — but progesterone protection is required to prevent endometrial hyperplasia
- Women with chronic anovulation should have a progesterone-induced withdrawal bleed at least 4×/year (e.g., medroxyprogesterone acetate 10 mg/day × 10 days)
Treatment options by goal:
| Situation | Treatment |
|---|
| Pregnancy desired | Clomiphene citrate; refer to gynecology |
| Contraception desired | Combined OCP, DMPA, or levonorgestrel IUD |
| Acute outpatient bleed | High-dose OCPs up to 4 pills/day × 5–7 days; then continuous cycling × 1 month |
| Acute inpatient bleed | IV fluids, IV estrogen, surgical consultation |
Components of the Physical Examination
The well-woman visit typically includes:
- Blood pressure measurement
- BMI/weight
- Breast examination (clinical value debated for average-risk women)
- Pelvic examination (as clinically indicated)
- STI screening as appropriate
- Mental health and depression screening
- Counseling on nutrition, physical activity, tobacco, alcohol, and intimate partner violence
Textbook of Family Medicine, 9e, Chapter 25